EUVIMEDEUVIMED entdecken
Open Access

How Do Prescribing Clinicians Obtain Consent to Initiate Gender-Affirming Hormones?

Gaines Blasdel iD, Avery Everhart iD, Colt St Amand, Monica Gaddis, Frances Grimstad iD

Transgender Health · 01.12.2023 · 8 (6) · 526-533

DOI: 10.1089/trgh.2021.0208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transgender Health, erschienen am 01.12.2023. Verfasst von Gaines Blasdel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, New York University Langone Health, New York, New York, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

gender-affirming hormone therapyinformed consent practicesstandards of caretransgender

Autor:innen und Institutionen

  • Department of Urology, New York University Langone Health, New York, New York, USA.
  • Population, Health, and Place Program, Spatial Sciences Institute, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, California, USA.
  • Department of Family Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Psychology, University of Houston, Houston, Texas, USA.
  • Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Biomedical and Health Informatics, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.

ORCID-Profile: Gaines Blasdel, Avery Everhart, Frances Grimstad

Zitieren

APA

Blasdel, G., Everhart, A., St Amand, C., Gaddis, M., & Grimstad, F. (2023). How Do Prescribing Clinicians Obtain Consent to Initiate Gender-Affirming Hormones?. Transgender Health, 8(6), 526-533. https://doi.org/10.1089/trgh.2021.0208

Vancouver

Blasdel G, Everhart A, St Amand C, Gaddis M, Grimstad F. How Do Prescribing Clinicians Obtain Consent to Initiate Gender-Affirming Hormones?. Transgender Health. 2023;8(6):526-533. doi:10.1089/trgh.2021.0208

BibTeX
@article{Blasdel2023,
  author = {Blasdel, Gaines and Everhart, Avery and St Amand, Colt and Gaddis, Monica and Grimstad, Frances},
  title = {How Do Prescribing Clinicians Obtain Consent to Initiate Gender-Affirming Hormones?},
  journal = {Transgender Health},
  year = {2023},
  volume = {8},
  number = {6},
  pages = {526--533},
  doi = {10.1089/trgh.2021.0208}
}
Kostenlos starten →